Mature chief cells are cryptic progenitors for metaplasia in the stomach

…, HJ Lee, JF Sousa, VG Weis, RL O'Neal, PE Finke… - Gastroenterology, 2010 - Elsevier
BACKGROUND & AIMS: Gastric cancer evolves in the setting of a pathologic mucosal milieu
characterized by both loss of acid-secreting parietal cells and mucous cell metaplasias. …

Structural Optimization Affording 2-(R)-(1-(R)-3,5-Bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent …

JJ Hale, SG Mills, M MacCoss, PE Finke… - Journal of medicinal …, 1998 - ACS Publications
Structural modifications requiring novel synthetic chemistry were made to the morpholine
acetal human neurokinin-1 (hNK-1) receptor antagonist 4, and this resulted in the discovery of 2…

The novel NK1 receptor antagonist MK–0869 (L–754,030) and its water soluble phosphoryl prodrug, L–758,298, inhibit acute and delayed cisplatin-induced emesis in …

…, S Tye, DJ Williamson, JJ Hale, SG Mills, PE Finke… - …, 2000 - Elsevier
The anti-emetic profile of the novel brain penetrant tachykinin NK 1 receptor antagonist MK–0869
(L–754,030) 2–(R)–(1–(R)–(3,5–bis(trifluoromethyl)phenylethoxy)–3–(S)–(4–fluoro)…

Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression

…, JF Sousa, BJ LaFleur, KT Nam, JA Weis, PE Finke… - Gut, 2013 - gut.bmj.com
Objectives Spasmolytic polypeptide-expressing metaplasia (SPEM) develops as a
preneoplastic lesion in the stomachs of mice and humans after parietal cell loss. To identify the …

Phosphorylated morpholine acetal human neurokinin-1 receptor antagonists as water-soluble prodrugs

…, SG Mills, M MacCoss, CP Dorn, PE Finke… - Journal of medicinal …, 2000 - ACS Publications
The regioselective dibenzylphosphorylation of 2 followed by catalytic reduction in the
presence of N-methyl-d-glucamine afforded 2-(S)-(1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(…

Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure–Activity relationships for 1-[N-(Methyl)-N-(phenylsulfonyl) amino]-2 …

PE Finke, B Oates, SG Mills, M MacCoss… - Bioorganic & medicinal …, 2001 - Elsevier
(2S)-2-(3-Chlorophenyl)-1-[N-(methyl)-N-(phenylsulfonyl)amino]-4-[spiro(2,3-dihydrobenzthiophene-3,4′-piperidin-1′-yl)]butane
S-oxide (1b) has been identified as a potent CCR5 …

Cephalosporin antibiotics can be modified to inhibit human leukocyte elastase

…, GO Chandler, ME Dahlgren, CP Dorn Jr, PE Finke… - Nature, 1986 - nature.com
Several laboratories, including our own, have reported the synthesis and activity of certain
low relative molecular mass inhibitors of mammalian serine proteases 1–4 , especially human …

The fibrinogen cleavage product Aα-Val360, a specific marker of neutrophil elastase activity in vivo

RI Carter, RA Mumford, KM Treonze, PE Finke… - Thorax, 2011 - thorax.bmj.com
Background Alpha-1-antitrypsin (A1AT) deficiency is the only recognised genetic risk factor
for chronic obstructive pulmonary disease (COPD), a leading cause of morbidity and …

Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infection

D Kim, L Wang, CG Caldwell, P Chen, PE Finke… - Bioorganic & medicinal …, 2001 - Elsevier
Finke a , Bryan Oates a , Malcolm MacCoss a , Sander G. Mills a , Lorraine Malkowitz b ,
Sandra L. Gould b , Julie A. … Feng, CC Broder, PE Kennedy, EA Berger … Dorn Jr., PE …

Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection

D Kim, L Wang, CG Caldwell, P Chen, PE Finke… - Bioorganic & medicinal …, 2001 - Elsevier
Replacement of the large hydantoin-indole moiety from our previous work with a variety of
smaller heterocyclic analogues gave rise to potent CCR5 antagonists having binding affinity …